Chee W. Tan
Adelaide, SA, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications
Adenoviral Inciting Antigen and Somatic Hypermutation in VITT.
Journal: The New England journal of medicine
Published: February 11, 2026
Clinical, psychological and quality of life outcomes up to 12-months following thrombosis with thrombocytopenia syndrome after ChAdOx1-S (AZD1222) vaccination in Australia.
Journal: Vaccine
Published: December 17, 2025
Durability of efficacy, safety, and quality of life 5 years after valoctocogene roxaparvovec gene transfer for severe hemophilia A: final phase 3 GENEr8-1 trial results.
Journal: Research and practice in thrombosis and haemostasis
Published: October 02, 2025
Measuring Direct Oral Anticoagulant (DOAC) Levels: Applications, Limitations, and Future Directions.
Measuring Direct Oral Anticoagulant (DOAC) Levels: Applications, Limitations, and Future Directions.
Journal: International journal of laboratory hematology
Published: February 07, 2025
2025 Guidelines for direct oral anticoagulants: a practical guidance on the prescription, laboratory testing, peri-operative and bleeding management.
Journal: Internal medicine journal
Published: September 30, 2024
Platelet factor 4 immune disease: medical emergencies that look like heparin-induced thrombocytopenia.
Journal: Internal medicine journal
Published: March 10, 2024
Unmet needs and barriers in venous thromboembolism education and awareness among people living with cancer: a global survey.
Journal: Journal of thrombosis and haemostasis : JTH
Published: November 20, 2023
Updated treatment options for immune thrombocytopenia.
Journal: Internal medicine journal
Published: July 28, 2023
The clinicopathological features of thrombosis with thrombocytopenia syndrome following ChAdOx1-S (AZD1222) vaccination and case outcomes in Australia: a population-based study.
Journal: The Lancet regional health. Western Pacific
Published: February 27, 2023
Health-related quality of life following valoctocogene roxaparvovec gene therapy for severe hemophilia A in the phase 3 trial GENEr8-1.
Journal: Journal of thrombosis and haemostasis : JTH
Published: December 13, 2022
Direct oral anticoagulants or vitamin K antagonists in emergencies: comparison of management in an observational study.
Journal: Research and practice in thrombosis and haemostasis
Published: December 04, 2022
Last Updated: 09/26/2026